DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Samatasvir
Samatasvir
A Randomized, Double-Blind, Multiple-Dose Study of the Pan-Genotypic NS5A Inhibitor Samatasvir in Patients Infected with Hepatitis C Virus Genotype 1, 2, 3 Or 4
Hepatitis Central.Com 2016 Was an Amazing Year for Hepatitis C Drug Progress
Mini-Review Advance Publication DOI: 10.5582/Bst.2016.01266
Current Treatment of Chronic Hepatitis C
An Update on the Management of Chronic Hepatitis C: 2015 Consensus Guidelines from the Canadian Association for the Study of the Liver
Sabrina Bagaglio*, Andrea Andolina, Marco Merli, Caterina Uberti-Foppa
HEPATITIS C MEDICINES Technology and Market Landscape
State of the Art Therapy for HCV
Viekira + Rbv 1-1.2 12 96%
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
Repurposing of FDA Approved Drugs
Advances in Hepatitis C Therapy: What Is the Current State - What Come's Next?
Naturally Occurring Resistance Mutations to Inhibitors of HCV
Appendix A: Online Search Strategies
Current Treatment of Chronic
Mini-Review DOI: 10.5582/Bst.2016.01266
Direct-Acting Antivirals
A New Era in Hepatitis C
Top View
Japanese Hepatitis C Market Forecast: Methodology and Implications
The Challenge of Treating Children with Hepatitis C Virus Infection Giuseppe Indolfi1, Claire Thorne2, Manal H. El Sayed3, Carlo
Randomized, Open-Label, Prospective Pilot Study Group a (N = 14) Group
Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight Into Drug Binding
Emerging Oral, Combination, Interferon-Free Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Author: Ron Pohar
Merck's Idenix Write-Off Another Bad Sign in Hep C
In Silico Drug Repurposing for COVID-19: Targeting SARS-Cov-2 Proteins Through Docking and Quantum Mechanical Scoring
Sofosbuvir + Ribavirin in HCV G1
In USA Or HCV Genotype 1A /1B in Europe
Hold the Interferon: Hcv Treatment in the Era of Direct Acting Antivirals
Global Elimination of Hepatitis C Virus Infection: Progresses and the Remaining Challenges
Long-Suffering Idenix Buffeted Again by J&J Deal
Rational Pricing and the Role of Generics Raymond F
New Therapies for Hepatitis C Virus Infection
New Era in the Management of Hepatitis C
Biotech Bull Market Charges with Merck's Idenix Takeout
In Combination with Simeprevir and Ribavirin In
Remdesivir from Wikipedia, the Free Encyclopedia
For the Treatment of Hepatitis C Has Been Initiated
Diplomarbeit
Interferon-Based Combination Treatment for Chronic Hepatitis C in the Era of Direct Acting Antivirals
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
An Update on the Management of Chronic Hepatitis C: 2015 Consensus Guidelines from the Canadian Association for the Study of the Liver
An Alternative Research and Development Strategy to Deliver Affordable Treatments for Hepatitis C Patients: the Drugs
HCV Eradication with Direct Acting Antivirals (Daas)?
209195Orig1s000
For the Treatment of Hepatitis C Virus Infection Initiated